The management of non-diagnostic soft tissue tumour biopsies using a multi-disciplinary team approach: A 10-year retrospective review at a specialist sarcoma unit.


Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 28 10 2022
revised: 21 01 2023
accepted: 08 02 2023
medline: 19 6 2023
pubmed: 23 2 2023
entrez: 22 2 2023
Statut: ppublish

Résumé

Non-Diagnostic (ND) biopsies are occasionally encountered during the investigation of soft tissue sarcoma. We performed a retrospective review of all ND soft tissue biopsies discussed at our regional Multi-Disciplinary Team (MDT) meeting between 2004 & 2014 with the aim of establishing the incidence of ND biopsies, identifying predictive factors for repeat biopsies and evaluating the effectiveness of MDT decisions. We identified 80 ND out of 3233 biopsies. Diagnostic Yield (DY) was 97.5%, 76.0% and 77.8% for the first, second and third successive biopsy respectively. With an MDT approach utilising radiological and clinical information, the diagnostic success rate achieved was 98.5%, 82.0% and 77.8% for the first, second and third biopsies respectively. Malignant tumours (sarcoma & carcinoma) were 19 times more likely to undergo an increasing number of biopsies compared to benign lesions (p < 0.01), while repeat biopsies were less useful for suspected benign lesion. Although a repeat biopsy was only performed in 63% of cases, there were no patients originally diagnosed with a benign lesion that re-presented with the same lesion subsequently being malignant throughout the study period. Our study shows that a specialist MDT approach leads to high diagnostic rates and is a safe and effective method of preventing unnecessary, repeat biopsies where the initial biopsy is ND.

Identifiants

pubmed: 36804280
pii: S0748-7983(23)00135-X
doi: 10.1016/j.ejso.2023.02.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1196-1202

Informations de copyright

Copyright © 2023 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that there is no conflict of interest regarding the publication of this paper.

Auteurs

Khabab Osman (K)

The Royal Orthopaedic Hospital, Birmingham, B31 2AP, United Kingdom; Birmingham Orthopaedic Network (BON), The Knowledge Hub, B31 2AP, United Kingdom. Electronic address: khabab.osman@nhs.net.

Shakir Hussain (S)

The Royal Orthopaedic Hospital, Birmingham, B31 2AP, United Kingdom; Birmingham Orthopaedic Network (BON), The Knowledge Hub, B31 2AP, United Kingdom.

Frederick Downes (F)

The Royal Orthopaedic Hospital, Birmingham, B31 2AP, United Kingdom.

Harshadkumar Dhirajlal Rajgor (HD)

The Royal Orthopaedic Hospital, Birmingham, B31 2AP, United Kingdom; Birmingham Orthopaedic Network (BON), The Knowledge Hub, B31 2AP, United Kingdom.

Vaiyapuri Sumathi (V)

The Royal Orthopaedic Hospital, Birmingham, B31 2AP, United Kingdom.

Rajesh Botchu (R)

The Royal Orthopaedic Hospital, Birmingham, B31 2AP, United Kingdom.

Scott Evans (S)

The Royal Orthopaedic Hospital, Birmingham, B31 2AP, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH